No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer's disease progression: a longitudinal study.
Saved in:
| Title: | No association between markers of systemic inflammation and endothelial dysfunction with Alzheimer's disease progression: a longitudinal study. |
|---|---|
| Authors: | van Setten A; Department of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands., Uleman JF; Copenhagen Health Complexity Center, Department of Public Health, University of Copenhagen, Oster Farimagsgade 5, 1353, Copenhagen K, Denmark. jeroen.uleman@sund.ku.dk., Melis RJF; Department of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands., Lawlor B; Global Brain Health Institute, Trinity College, Dublin, Ireland., Riksen NP; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Claassen JAHR; Department of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., de Heus RAA; Department of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands. |
| Corporate Authors: | NILVAD Study Group |
| Source: | GeroScience [Geroscience] 2025 Feb; Vol. 47 (1), pp. 1093-1104. Date of Electronic Publication: 2024 Jul 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
